
Meet VMI-Trac™
Non-invasive imaging analytics for immune and stem cell therapy development
Safe and Effective
VMI-Trac™ is a revolutionary cells imaging system that has been validated in multiple immune and stem cell types and exhibited no long-term effect or toxicity on cellular physiology or function of the labeled cells. The locations of labeled cells can be monitored using standard clinically available imaging techniques, such as MRI.
TM


Seamless Integration
The biodistribution and targeting of VMI-Trac™ labeled cells can be monitor in real time in vivo using conventional MRI system thus easily integrate with existing disease monitor workflow.
Preclinical to Clinical Continuum
Use VMI-Trac™ to accelerate your cell therapy development. Whether it is for lead candidate selection in early discovery, acquisition of FDA required biodistribution/toxicity/efficacy data for IND submission in Preclinical phase, or help clinicians better understand and predict the therapeutic efficacy of cell therapy in clinical trials.

A VMI-Trac™ to meet your specific cell tracking needs
Specifically formulated to meet the demands of cell therapy developers. Choose from our family of VMI-TRAC™ products that is right for your application.
The VMI-Trac™ labeling system include everything you need to label your immune or stem cells for in vivo tracking.
Product | Detection | Cell Type | Research Use | Clinical Trial Use |
|---|---|---|---|---|
VMI-Trac Plus | MRI | Most stem cells | ||
VMI-Trac Pro | MRI | Mesenchymal stem cells/Heterogeneous population (Difficult to label, low phagocytic) | ||
VMI-Trac Ultra | MRI | Immune cells (Therapeutic T and NK cell including CAR-T and CAR-NK) | ||
VMI-Trac Duo | MRI/Fluorescence | Customized‡ |
† In development
‡ customized for individual tracking needs
